Fig. 1From: SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− miceStudy design, 55 mice arrived at 6 weeks of age and acclimatized for 1 week prior to entry into the studyBack to article page